Suman Paul

17PUBLICATIONS
87CO-AUTHORS
Molecular targetsHaematologyCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 20, 2026
A PBD dimer-containing antibody-drug conjugate targeting CCRL2 for high-risk MDS/AML including TP53-mutated disease.

|Apr 14, 2026
A plasma-based DNA test for quantification of disease burden in acute myeloid leukemia patients undergoing bone marrow transplantation.

Yuxuan Wang, Jiajun Xie, Sergiu Pasca

|Mar 16, 2026
Lethal toxin-equipped effector cells for the potential treatment of cancer.

Alexander H Pearlman, Brian J Mog, Michael S Hwang

|Dec 22, 2025
TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers.

Jiaxin Ge, Joshua Urban, Sarah R DiNapoli

|Nov 24, 2025
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML.

Theodoros Karantanos, Nour Naji, Taha Ahmedna

|Aug 25, 2025
Detection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM.

Alexander H Pearlman, Yuxuan Wang, Anita Kalluri

Pageof 3

Frequent Collaborators

12 joint publications

Maximilian F Konig

10 joint publications

Alexander H Pearlman

10 joint publications

Bert Vogelstein

9 joint publications

Nickolas Papadopoulos